Home › Coronary Artery Disease › Alabama › Birmingham
Coronary Artery Disease clinical trials in Birmingham, AL
6 studies for Coronary Artery Disease are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Cardiology, PC, Birmingham
Product Surveillance Registry
RecruitingObservational study
- Birmingham, Birmingham
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
RecruitingPhase 2
- Alabama Cardiology PC, Birmingham
Prevail Global Study
Recruiting
- The University of Alabama at Birmingham, Birmingham
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
RecruitingPhase 4
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Recruiting
- Cardiology, PC - Princeton Baptist Medical Center, Birmingham
About Coronary Artery Disease
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
More about Coronary Artery Disease on MedlinePlus
Coronary Artery Disease trials in other cities
- New York City, NY21 studies
- Boston, MA16 studies
- Dallas, TX15 studies
- Atlanta, GA15 studies
- Jacksonville, FL14 studies
- Minneapolis, MN13 studies
- Cleveland, OH13 studies
- Nashville, TN11 studies
- Columbus, OH10 studies
- Durham, NC9 studies
- Houston, TX8 studies
- Memphis, TN8 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Ovarian Cancer23 studies
- Obesity23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Type 2 Diabetes16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.